BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10188638)

  • 1. Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain.
    Tremblay M; Rouillard C; Lévesque D
    Synapse; 1999 Apr; 32(1):51-7. PubMed ID: 10188638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain.
    Tremblay M; Rouillard C; Lévesque D
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):857-82. PubMed ID: 9723125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and dopamine D3 receptor antisense reduce cocaine- and amphetamine-regulated transcript expression in the rat nucleus accumbens shell.
    Beaudry G; Zekki H; Rouillard C; Lévesque D
    Synapse; 2004 Mar; 51(4):233-40. PubMed ID: 14696011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain.
    Southam E; Lloyd A; Jennings CA; Cluderay JE; Cilia J; Gartlon JE; Jones DN
    Brain Res; 2007 May; 1149():50-7. PubMed ID: 17382304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja.
    Gurevich EV; Himes JW; Joyce JN
    J Pharmacol Exp Ther; 1999 Apr; 289(1):587-98. PubMed ID: 10087054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute methamphetamine administration upregulates NGFI-B mRNA expression in the striatum: co-localization with c-Fos immunoreactivity.
    Bäckman C; Morales M
    Synapse; 2002 Jun; 44(3):158-65. PubMed ID: 11954047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D3 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens.
    Tremblay M; Rouillard C; Lévesque D
    Neuroreport; 1997 Dec; 8(18):3901-5. PubMed ID: 9462463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective action of D2 dopamine receptor antisense oligodeoxynucleotide on the expression of the dopamine receptor subtype mRNA in rat striatum.
    Andoh H; Yoshikawa M; Kawaguchi M; Matsumoto H; Yamazaki K; Oka T
    Tokai J Exp Clin Med; 2006 Jul; 31(2):73-7. PubMed ID: 21302227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S
    Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
    Le Foll B; Diaz J; Sokoloff P
    Synapse; 2003 Mar; 47(3):176-83. PubMed ID: 12494400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
    Merchant KM
    Mol Cell Neurosci; 1994 Aug; 5(4):336-44. PubMed ID: 7804603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW; Zhang SP; Qin ZH; Weiss B
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat.
    Schmidt HD; Anderson SM; Pierce RC
    Eur J Neurosci; 2006 Jan; 23(1):219-28. PubMed ID: 16420431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH
    Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system.
    Rossner S; Perez-Polo JR; Wiley RG; Schliebs R; Bigl V
    J Neurosci Res; 1994 Jun; 38(3):282-93. PubMed ID: 7932863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors.
    Hunter RG; Jones D; Vicentic A; Hue G; Rye D; Kuhar MJ
    Neuropharmacology; 2006 Jun; 50(7):858-64. PubMed ID: 16458333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
    Maheux J; Ethier I; Rouillard C; Lévesque D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.